MedPath

Effects of Temporary Inhibition of the Renin-Angiotensin System on future blood pressure and hypertensive organ damage in young prehypertensive adults * TIResiAS

Phase 4
Conditions
elevated blood pressure
hypertension
10057166
Registration Number
NL-OMON30810
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

Included are persons aged 18-40 years with an average blood pressure of 130-139 systolic/below 90 mmHg diastolic and/or below 130 systolic/ 85-89 mmHg diastolic on 3 separate office visits with an interval of one week as measured by an automated blood pressure device (Omron M4).

Exclusion Criteria

Excluded are persons with any (chronic) disease requiring medication or specialist treatment, patients with 3 or more risk factors according to current ESH guidelines, an elevated baseline serum glucose or elevated serum creatinine and females with a wish to become pregnant in the treatment period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath